Compared with non-Hispanic White patients, of whom 66.1% had ERBB2-low breast cancer, Native American patients had a higher proportion of ERBB2-low disease (2270 [70.0%]), while the proportions were lower in non-Hispanic Black (62.8%) and Hispanic (61.0%) patients. The gene discussed is ERBB2; the disease is breast cancer.